# Enteral Glutamine in Critical Illness

> **NCT00318331** · PHASE2,PHASE3 · TERMINATED · sponsor: **Christiana Care Health Services** · enrollment: 20 (actual)

## Conditions studied

- Critical Illness
- Sepsis
- Respiratory Insufficiency

## Interventions

- **DRUG:** Glutamine

## Key facts

- **NCT ID:** NCT00318331
- **Lead sponsor:** Christiana Care Health Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Unable to meet enrollment numbers
- **Last updated:** 2008-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318331, "Enteral Glutamine in Critical Illness". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00318331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*